Curis and Genentech Join Forces Again
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 59 (Table of Contents)
Published: 5 May-2005
DOI: 10.3833/pdr.v2005.i59.677 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Curis and Genentech entered into licensing agreement to discover and develop small molecule modulators of pathways that control progenitor cell proliferation and differentiation...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS